
Please try another search
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. It operates through two segments; Domestic and Overseas. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from Tablets, Capsules, Injectable, Patches, eye drops, and other products. It also offers IT service related to healthcare; disease risk testing services; and quasi drugs. In addition, the company is involved in research and development and production of active pharmaceutical ingredients, intermediates, support business; and planning, development and OEM manufacturing of health foods, pharmaceuticals, general foods, and other miscellaneous merchandizes. The company was founded in 1951 and is headquartered in Osaka, Japan.
Name | Age | Since | Title |
---|---|---|---|
Itsuro Yoshida | 71 | 1983 | President & Representative Director |
Kenichi Inoue | - | 2023 | Director |
Masao Tanaka | 70 | 2017 | Director |
Kenryo Goto | 66 | 2021 | Independent Outside Director |
Toshikazu Kokubun | - | 2024 | Director |
Kaori Oishi | 47 | 2020 | Independent Outside Director |
Nobuki Ando | 70 | 2024 | Independent Outside Director |
Masaaki Takeyasu | 60 | 2024 | Director |
Osamu Uchikawa | 67 | 2018 | Executive MD & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review